HU0600097D0 - Pharmaceutical composition comprising tacrolimus - Google Patents
Pharmaceutical composition comprising tacrolimusInfo
- Publication number
- HU0600097D0 HU0600097D0 HU0600097A HUP0600097A HU0600097D0 HU 0600097 D0 HU0600097 D0 HU 0600097D0 HU 0600097 A HU0600097 A HU 0600097A HU P0600097 A HUP0600097 A HU P0600097A HU 0600097 D0 HU0600097 D0 HU 0600097D0
- Authority
- HU
- Hungary
- Prior art keywords
- tacrolimus
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960001967 tacrolimus Drugs 0.000 title 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0600097A HUP0600097A3 (en) | 2006-02-08 | 2006-02-08 | Pharmaceutical compositions comprising tacrolimus and process for their preparation |
| PCT/HU2007/000005 WO2007091109A1 (en) | 2006-02-08 | 2007-02-08 | Pharmaceutical composition comprising tacrolimus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0600097A HUP0600097A3 (en) | 2006-02-08 | 2006-02-08 | Pharmaceutical compositions comprising tacrolimus and process for their preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0600097D0 true HU0600097D0 (en) | 2006-03-28 |
| HUP0600097A2 HUP0600097A2 (en) | 2007-09-28 |
| HUP0600097A3 HUP0600097A3 (en) | 2008-07-28 |
Family
ID=89986573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0600097A HUP0600097A3 (en) | 2006-02-08 | 2006-02-08 | Pharmaceutical compositions comprising tacrolimus and process for their preparation |
Country Status (2)
| Country | Link |
|---|---|
| HU (1) | HUP0600097A3 (en) |
| WO (1) | WO2007091109A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2008000374A1 (en) | 2008-02-05 | 2008-04-04 | Igloo Zone Chile S A | PHARMACEUTICAL COMPOSITION THAT INCLUDES A POWDER FOR ORAL SUSPENSION OF TACROLIMUS OR ONE OF ITS SALTS, HYDRATES OR SOLVATOS AND EXCIPIENTS PHARMACEUTICALLY ACCEPTABLE; PROCEDURE FOR PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION; AND USE FOR PREVE |
| FR2943539B1 (en) | 2009-03-31 | 2011-07-22 | Ethypharm Sa | PHARMACEUTICAL COMPOSITION COMPRISING A IMMUNOSUPPRESSIVE MACROLIDE OF THE LIMUS FAMILY. |
| CN104840446B (en) * | 2015-05-27 | 2017-08-11 | 福建科瑞药业有限公司 | A kind of pharmaceutical composition of tacrolimus and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204243B1 (en) * | 1993-09-01 | 2001-03-20 | Novatis Ag | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis |
| JP3714970B2 (en) * | 1998-03-26 | 2005-11-09 | アステラス製薬株式会社 | Sustained release formulation |
| US20070122482A1 (en) * | 2003-10-03 | 2007-05-31 | Per Holm | Method for preparing modified release pharmaceutical compositions |
-
2006
- 2006-02-08 HU HU0600097A patent/HUP0600097A3/en unknown
-
2007
- 2007-02-08 WO PCT/HU2007/000005 patent/WO2007091109A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007091109A1 (en) | 2007-08-16 |
| HUP0600097A3 (en) | 2008-07-28 |
| HUP0600097A2 (en) | 2007-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2001498A4 (en) | Pharmaceutical compositions | |
| IL194176A0 (en) | Pharmaceutical compositions | |
| GB0713625D0 (en) | Pharmaceutical compositions | |
| PL2101740T3 (en) | New non-abusable pharmaceutical composition comprising opioids | |
| PL2124556T3 (en) | Pharmaceutical compositions | |
| ZA200808530B (en) | Pharmaceutical composition for external use | |
| EP2018150A4 (en) | Pharmaceutical composition having reduced abuse potential | |
| ZA200808531B (en) | Pharmaceutical composition for external use | |
| LT3984528T (en) | Pharmaceutical compositions comprising nilotinib | |
| EP2119442A4 (en) | Tacrolimus sustained release pharmaceutical composition | |
| ZA200806318B (en) | Drug combinations | |
| GB0608724D0 (en) | Novel Pharmaceutical Compositions | |
| GB0614586D0 (en) | Pharmaceutical Formulation | |
| GB0610322D0 (en) | Novel pharmaceutical compositions | |
| EP2124959A4 (en) | Pharmaceutical composition | |
| IL198160A0 (en) | Pharmaceutical formulations | |
| GB0625783D0 (en) | Medicament | |
| HU0600097D0 (en) | Pharmaceutical composition comprising tacrolimus | |
| GB0615064D0 (en) | Medicament | |
| GB0615814D0 (en) | Medicament | |
| ZA200708369B (en) | Medicament | |
| GB0612696D0 (en) | Pharmaceutical composition | |
| GB0600032D0 (en) | Pharmaceutical composition | |
| GB0617578D0 (en) | Pharmaceutical composition | |
| GB0609941D0 (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |